Enterococcus casseliflavus
Enterococcus casseliflavus is an intrinsically vancomycin-resistant enterococcal species (meaning resistance is encoded in its chromosome, not acquired through gene transfer) found in environmental and food settings as well as the gastrointestinal tracts of animals and humans. Its research record consists primarily of clinical case reports of opportunistic infection — including osteomyelitis and spontaneous bacterial peritonitis — antibiotic resistance surveillance, and environmental isolate studies. One report also noted aerobic degradation of a brominated flame retardant compound by an E. casseliflavus isolate, reflecting its metabolic versatility in environmental contexts. This species is not a recognized probiotic organism; it is an opportunistic pathogen of clinical concern, particularly in immunocompromised individuals, and is described here in a taxonomic and epidemiological context only.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 234 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 35 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
922 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 38792783 →Identification and Safety Assessment of Enterococcus casseliflavus KB1733 Isolated from Traditional Japanese Pickle Based on Whole-Genome Sequencing Analysis and Preclinical Toxicity Studies· Microorganisms · 2024
-
[2]
PMID 31393924 →Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation· PLoS ONE · 2019
-
[3]
Source →Pre-Engraftment Gut Colonization with Enterococcus Casseliflavus Improves Survival after Allogeneic Hematopoietic Cell Transplantation· Blood · 2018
-
[4]
Source →Favorable Outcomes in Patients with Pre-Transplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci· Biology of Blood and Marrow Transplantation · 2018